Immunohistochemical Evaluation of Apoptosis and Multidrug Resistance- Related Markers in Gallbladder Dysplasia and Carcinoma

dc.authoridhttps://orcid.org/0000-0003-1960-8924en_US
dc.authoridhttps://orcid.org/0000-0002-6333-8856en_US
dc.authoridhttps://orcid.org/0000-0002-3689-3061en_US
dc.authoridhttps://orcid.org/0000-0002-5892-3735en_US
dc.contributor.authorBaşak, Kayhan
dc.contributor.authorDemir, Derya
dc.contributor.authorKaya Koçdoğan, Arzu
dc.contributor.authorOğuztüzün, Serpil
dc.date.accessioned2023-12-28T14:03:32Z
dc.date.available2023-12-28T14:03:32Z
dc.date.issued2022en_US
dc.departmentSağlık Hizmetleri Meslek Yüksekokuluen_US
dc.description.abstractObjective: The search for treatment success in gallbladder carcinomas, which is one of the tumors with the most aggressive course, poor prognosis, and tendency to show resistance to treatment, continues today. Treatments targeting pathways related to genetic changes de- tected in most solid tumors offer new hope in the treatment of these tumors. Some of these treatment modalities target apoptosis-related pathways, and mammalian target of rapamycin (mTOR), p38, Bcl-2, and caspase-3 are important components of this pathway. Methods: In the study, mTOR, caspase-3, p38, Bcl-2, LL-37, MDR1, multidrug resistance protein (MRP)1, MRP6, and MRP7 immunohistochemical staining were applied to paraffin blocks of 27 gallbladder cancer and 62 cases with gallbladder dysplasia. The immunohisto- chemically stained sections were evaluated and scored. Results: mTOR, p38, and caspase-3 expressions were found to be significantly increased in dysplasia and tumor groups, and in dysplastic and malignant cells. While there was no signifi- cant difference in the expression of MRP1 and MRP7, MRP6 was significantly overexpressed. Conclusion: In this study, increased expression of mTOR, p38, and caspase-3 in the dys- plastic and malignant cells of the gallbladder may show that it has a role in the carcinogenesis process in the gallbladder. The study also shows that MRP6 may also play a role in the devel- opment of drug resistance in gallbladder carcinoma.en_US
dc.identifier.doi10.14744/scie.2022.82712en_US
dc.identifier.endpage428en_US
dc.identifier.issn2587-0998
dc.identifier.issn2587-1404
dc.identifier.issue4en_US
dc.identifier.startpage423en_US
dc.identifier.trdizinid1171579en_US
dc.identifier.urihttps://hdl.handle.net/11363/6815
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1171579
dc.identifier.urihttps://doi.org/
dc.identifier.volume33en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorKaya Koçdoğan, Arzu
dc.language.isoenen_US
dc.publisherKartal Dr. Lütfi Kırdar Eğitim ve Araştırma Hastanesien_US
dc.relation.ispartofSouthern Clinics of Istanbul Eurasiaen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectApoptosisen_US
dc.subjectGallbladder carcinomaen_US
dc.subjectGallbladder dysplasiaen_US
dc.subjectMultidrug resistanceen_US
dc.titleImmunohistochemical Evaluation of Apoptosis and Multidrug Resistance- Related Markers in Gallbladder Dysplasia and Carcinomaen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
document (3).pdf
Boyut:
2.3 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale / Article
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: